FAB — Fusion Antibodies Share News
0.000.00%
- £20.00m
- £20.14m
- £1.97m
REG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 30/01/2026
AnnouncementREG - Fusion Antibodies - Issue of Director Shares
AnnouncementREG - Fusion Antibodies - Placing and Subscription to raise approx £1.4m
AnnouncementREG - Fusion Antibodies - Update on negotiations with NCI regarding OptiMAL
AnnouncementREG - Fusion Antibodies - Launch of OptiMAL platform
AnnouncementRCS - Fusion Antibodies - Mammalian Display video
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Half-year Financial Report
AnnouncementREG - Fusion Antibodies - Notice of Results
AnnouncementRCS - Fusion Antibodies - OptiMAL Library video
AnnouncementREG - Fusion Antibodies - OptiMAL® R&D Update
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Result of AGM
AnnouncementREG - Fusion Antibodies - AGM statement and H1 trading update
AnnouncementREG - Fusion Antibodies - Contract win
AnnouncementREG - Fusion Antibodies - Posting of Annual Report & Notice of AGM
AnnouncementREG - Fusion Antibodies - OptiMAL R&D Update
Announcement